ADC Therapeutics SA (ADCT)

ADC Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 21, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	498	192	134	307	1,550	2,485
Market Cap Growth	60.95%	43.49%	-56.31%	-80.20%	-37.60%	-
Enterprise Value	721	373	259	264	1,340	2,030
Last Close Price	4.02	1.99	1.66	3.84	20.20	32.01
PS Ratio	6.19	2.72	1.93	1.46	45.71	-
PB Ratio	-	-0.95	-0.90	3.86	9.34	7.41
P/TBV Ratio	-	-	-	3.86	10.12	7.64
EV/Sales Ratio	9.58	5.26	3.73	1.26	39.51	-
Debt / Equity Ratio	-1.92	-2.19	-2.89	4.15	1.97	0.13
Asset Turnover	0.24	0.21	0.17	0.38	0.06	-
Inventory Turnover	6.94	6.69	9.18	16.36	-	-
Quick Ratio	4.15	3.37	4.49	4.88	6.75	10.90
Current Ratio	4.63	3.82	4.97	5.31	7.10	11.14
Return on Equity (ROE)	-	-	-	-127.99%	-91.72%	-110.28%
Return on Assets (ROA)	-23.98%	-24.13%	-24.54%	-13.91%	-28.91%	-42.03%
Return on Capital (ROIC)	-30.53%	-31.40%	-30.12%	-17.08%	-37.57%	-55.48%
Return on Capital Employed (ROCE)	-53.80%	-54.10%	-57.80%	-30.20%	-48.10%	-46.30%
Earnings Yield	-33.52%	-82.03%	-179.01%	-51.19%	-14.84%	-9.91%
FCF Yield	-26.56%	-64.81%	-90.91%	-45.28%	-15.27%	-6.82%
Buyback Yield / Dilution	-26.73%	-18.91%	-4.55%	-1.83%	-17.33%	-32.73%

Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q